Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00343382 · ClinicalTrials.gov registry record · Phase 3
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 201
- Enrollment target
NCT00343382 is a Phase 3 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 201 participants.
The verdict
NCT00343382, a Phase 3 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 201 participants
- Enrollment target
Study Summary
RATIONALE: Pilocarpine may decrease vaginal dryness and improve quality of life in patients with breast cancer It is not yet known whether pilocarpine is more effective than a placebo in treating vaginal dryness in patients with breast cancer. PURPOSE: This randomized phase III trial is studying pilocarpine to see how well it works compared to a placebo in treating vaginal dryness in patients with breast cancer.
Interventions
- OTHER placebo
- DRUG pilocarpine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00343382
The ClinicalTrials.gov registry entry for NCT00343382 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00343382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00343382 about?
NCT00343382 is a clinical study titled "Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer". RATIONALE: Pilocarpine may decrease vaginal dryness and improve quality of life in patients with breast cancer It is not yet known whether pilocarpine is more effective than a placebo in treating vaginal dryness in patients with breast cancer. PURPOSE: This randomized phase III trial is studying pi...
What is the current status of trial NCT00343382?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 201 participants. The study started on 2006-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00343382?
The interventions under investigation include: placebo (OTHER), pilocarpine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00343382?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.